4
Changes in Ownership
CORCEPT THERAPEUTICS INC Filed Acc 0001193125-25-307204
Chief Executive Officer sold 40,000 shares at $79.77 ($3,190,796)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
BELANOFF JOSEPH K · Chief Executive Officer
Table I: Non-derivative
1 line| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-12-01 | Sale : show line 1 in the form 10b5-1 | −40,000 | $79.77 | $3,190,796 | 2,701,370 | I |
| Open-market sales · 40,000 sh · avg $79.77 · $3,190,796 | ||||||
Loading xslF345X05/ownership.xml…